Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.
Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.
Arch Acad Emerg Med. 2020;8(1):e51
Authors: Abdollahimajd F, Shahidi-Dadras M, M Robati R, Dadkhahfar S
Abstract
The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment of pemphigus with a focus on the lessons from similar epidemics to find a proper suggestion to manage pemphigus in the COVID-19 pandemic era. The effect of many of the drugs used for treatment of Pemphigus vulgaris (PV) on COVID-19 is not clear. We also do not have data on the impact of this autoimmune disease, which may involve the mucous membranes, on the acquisition or course of COVID-19. We are currently in the midst of a pandemic and evaluating the effect of COVID-19 on the population of susceptible patients suffering from auto-immune diseases like pemphigus is essential. The evidence on best ways to manage patients with underlying conditions, such as pemphigus, during the outbreak of COVID-19 is evolving and the data is updated every day.
PMID: 32440662 [PubMed]
Source: Accident and Emergency Nursing - Category: Emergency Medicine Authors: Abdollahimajd F, Shahidi-Dadras M, M Robati R, Dadkhahfar S Tags: Arch Acad Emerg Med Source Type: research
More News: Accidents | Autoimmune Disease | Coronavirus | COVID-19 | Dermatology | Emergency Medicine | Epidemics | Epidemiology | Lessons | Nurses | Nursing | Outbreaks | Pandemics | Pemphigus | Skin